Antifungal resistance among Candida species.

作者: Michael E. Klepser

DOI: 10.1592/PHCO.21.12.124S.34511

关键词:

摘要: Isolation of Candida sp less susceptible to traditional therapies and recovery increasingly resistant isolates during antifungal therapy are growing problems. It is important for clinicians be aware trends mechanisms responsible the expression resistance.

参考文章(85)
R Le Guennec, J Reynes, M Mallié, C Pujol, F Janbon, J M Bastide, Fluconazole- and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities. Journal of Clinical Microbiology. ,vol. 33, pp. 2732- 2737 ,(1995) , 10.1128/JCM.33.10.2732-2737.1995
M A Pfaller, J Rhine-Chalberg, S W Redding, J Smith, G Farinacci, A W Fothergill, M G Rinaldi, Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. Journal of Clinical Microbiology. ,vol. 32, pp. 59- 64 ,(1994) , 10.1128/JCM.32.1.59-64.1994
M B Kurtz, G Abruzzo, A Flattery, K Bartizal, J A Marrinan, W Li, J Milligan, K Nollstadt, C M Douglas, Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies. Infection and Immunity. ,vol. 64, pp. 3244- 3251 ,(1996) , 10.1128/IAI.64.8.3244-3251.1996
Jose L. Lopez-Ribot, Robert K. McAtee, Linda N. Lee, William R. Kirkpatrick, Theodore C. White, Dominique Sanglard, Thomas F. Patterson, Distinct patterns of gene expression associated with development of fluconazole resistance in serial Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis Antimicrobial Agents and Chemotherapy. ,vol. 42, pp. 2932- 2937 ,(1998) , 10.1128/AAC.42.11.2932
Michael E. Klepser, Erika J. Ernst, Michael E. Ernst, Shawn A. Messer, Michael A. Pfaller, Evaluation of Endpoints for Antifungal Susceptibility Determinations with LY303366 Antimicrobial Agents and Chemotherapy. ,vol. 42, pp. 1387- 1391 ,(1998) , 10.1128/AAC.42.6.1387
M Ruhnke, A Eigler, I Tennagen, B Geiseler, E Engelmann, M Trautmann, Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. Journal of Clinical Microbiology. ,vol. 32, pp. 2092- 2098 ,(1994) , 10.1128/JCM.32.9.2092-2098.1994
Stephanie A. Yoon, Jose A. Vazquez, Paul E. Steffan, Jack D. Sobel, Robert A. Akins, High-Frequency, In Vitro Reversible Switching of Candida lusitaniae Clinical Isolates from Amphotericin B Susceptibility to Resistance Antimicrobial Agents and Chemotherapy. ,vol. 43, pp. 836- 845 ,(1999) , 10.1128/AAC.43.4.836
M. Christine Broughton, M. Bard, N. D. Lees, Polyene resistance in ergosterol producing strains of Candida albicans. Mycoses. ,vol. 34, pp. 75- 83 ,(2009) , 10.1111/J.1439-0507.1991.TB00623.X
F. de Lalla, G. Pellizzer, A. Vaglia, V. Manfrin, M. Franzetti, P. Fabris, C. Stecca, Amphotericin B as primary therapy for cryptococcosis in patients with AIDS : reliability of relatively high doses administered over a relatively short period Clinical Infectious Diseases. ,vol. 20, pp. 263- 266 ,(1995) , 10.1093/CLINIDS/20.2.263
Pascal Chavanet, José Lopez, Michèle Grappin, Alain Bonnin, Michel Duong, Anne Waldner, Marielle Buisson, Patrick Camerlynck, Henri Portier, Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients. AIDS. ,vol. 8, pp. 945- 950 ,(1994) , 10.1097/00002030-199407000-00011